<?xml version="1.0" ?>
<TABLE>
<ENTRY>
<ID>CHEBI:18304</ID>
<NAME>deamido-NAD(+)</NAME>
<STAR>3</STAR>
<SECONDARY_ID>CHEBI:4340</SECONDARY_ID>
<SECONDARY_ID>CHEBI:14103</SECONDARY_ID>
<SECONDARY_ID>CHEBI:14104</SECONDARY_ID>
<SECONDARY_ID>CHEBI:23567</SECONDARY_ID>
<SYNONYM>Deamino-NAD+</SYNONYM>
<SYNONYM>Deamido-NAD+</SYNONYM>
<SYNONYM>Deamido-NAD</SYNONYM>
<IUPAC_NAME>adenosine 5'-{3-[1-(3-carboxypyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate}</IUPAC_NAME>
<FORMULA>C21H27N6O15P2</FORMULA>
<MASS>665.41804</MASS>
<MONOISOTOPIC_MASS>665.101</MONOISOTOPIC_MASS>
<CHARGE>1</CHARGE>
<SMILES>Nc1ncnc2n(cnc12)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)[n+]2cccc(c2)C(O)=O)[C@@H](O)[C@H]1O</SMILES>
<INCHI>InChI=1S/C21H26N6O15P2/c22-17-12-18(24-7-23-17)27(8-25-12)20-16(31)14(29)11(41-20)6-39-44(36,37)42-43(34,35)38-5-10-13(28)15(30)19(40-10)26-3-1-2-9(4-26)21(32)33/h1-4,7-8,10-11,13-16,19-20,28-31H,5-6H2,(H4-,22,23,24,32,33,34,35,36,37)/p+1/t10-,11-,13-,14-,15-,16-,19-,20-/m1/s1</INCHI>
<INCHIKEY>SENPVEZBRZQVST-HISDBWNOSA-O</INCHIKEY>
<DRUGBANK_ACCESSION>DB04099</DRUGBANK_ACCESSION>
<KEGG_COMPOUND_ACCESSION>C00857</KEGG_COMPOUND_ACCESSION>
<PDBECHEM_ACCESSION>NXX</PDBECHEM_ACCESSION>
</ENTRY>
</TABLE>
